WisdomTree BioRevolution Fund Rating $14.54 +1.27 (+9.60%) Closing price 09/12/2025 03:50 PM EasternExtended Trading$14.52 -0.02 (-0.10%) As of 09/12/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.71Holdings in WDNA have an aggregate rating of Moderate Buy based on 298 analyst ratings issued in the past year covering 23 companies (46.9% of the portfolio).WDNA Aggregate Price Target$14.54High Prediction$14.54Average Prediction$14.54Low Prediction$14.54Holdings in WDNA have an aggregate price target of $14.54 and a range of $14.54 to $14.54 covering 23 companies (46.9% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.99%NTLAIntellia Therapeutics$11.424.3884 of 5 stars2.56$27.11 137.4%18Positive NewsAnalyst Revision2.71%CRSPCRISPR Therapeutics$56.26+0.7%3.2836 of 5 stars2.47$71.60 27.3%17News Coverage2.62%NTRANatera$168.51-3.0%3.6599 of 5 stars3.06$194.00 15.1%18News CoveragePositive News2.52%DNAGinkgo Bioworks$10.02-4.0%1.8099 of 5 stars2.33$9.50 -5.2%3Positive News2.30%STOKStoke Therapeutics$23.46-1.8%3.9315 of 5 stars3.22$25.57 9.0%9Positive News2.30%ARCTArcturus Therapeutics$17.32-4.0%3.1741 of 5 stars3.00$50.57 192.0%8Positive News2.16%UTHRUnited Therapeutics$405.02+0.0%4.7853 of 5 stars2.69$438.85 8.4%13Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.14%IONSIonis Pharmaceuticals$63.16-1.4%3.6616 of 5 stars2.81$67.88 7.5%16Insider Trade2.13%LLYEli Lilly and Company$754.90-0.2%4.9965 of 5 stars2.68$941.35 24.7%22Trending News2.11%RGNXREGENXBIO$9.20-3.1%4.6005 of 5 stars2.83$28.38 208.4%62.07%AGIOAgios Pharmaceuticals$36.78+0.8%4.3179 of 5 stars2.75$56.00 52.3%8Insider Trade2.03%BEAMBeam Therapeutics$20.60-4.4%2.8598 of 5 stars3.08$46.40 125.2%13Analyst Downgrade1.95%TXG10x Genomics$12.64-3.2%3.5967 of 5 stars2.33$13.65 8.0%15News CoverageAnalyst Forecast1.94%GILDGilead Sciences$114.55-2.8%4.9086 of 5 stars2.89$115.39 0.7%27Positive News1.93%SANASana Biotechnology$3.22-5.3%3.06 of 5 stars3.00$8.00 148.4%6News Coverage1.92%VCYTVeracyte$30.88-3.1%3.7598 of 5 stars2.70$40.90 32.4%101.85%EDITEditas Medicine$2.69-0.7%4.1991 of 5 stars2.23$5.10 89.6%131.74%TEMTempus AI$86.38-2.7%1.9177 of 5 stars2.54$70.17 -18.8%13Trending NewsAnalyst ForecastOptions Volume1.62%BNTXBioNTech$96.74-7.3%2.5143 of 5 stars2.76$135.80 40.4%17Gap DownHigh Trading Volume1.48%AZNAstraZeneca$79.56-1.9%2.7905 of 5 stars2.75$86.00 8.1%4Trending NewsShort Interest ↑Analyst Revision1.48%MRNAModerna$23.51-7.4%4.4665 of 5 stars2.05$41.81 77.8%22News CoverageHigh Trading Volume1.46%TWSTTwist Bioscience$25.31-1.2%3.9587 of 5 stars2.73$49.40 95.2%11News Coverage1.46%FOLDAmicus Therapeutics$7.99-0.4%3.9591 of 5 stars2.78$16.00 100.3%9Positive News This page (BATS:WDNA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts